Transcatheter Technologies GmbH has expanded the Trinity technology platform to include a transfemoral version.
In September, Transcatheter Technologies disclosed at the TCT 2014 scientific meeting the successful one-year follow-up results of its Trinity transapical TAVI system, designed to be the world’s best TAVI system. The Trinity aortic valve can be positioned precisely or even repositioned after full implantation in a safe manner. Trinity’s sealing cuff continues to provide successful results without paravalvular leak, a frequent complication of TAVI. Furthermore, the risk of atrio-ventricular block has been essentially alleviated because of the supra-annular anchoring of the Trinity valve.
“The transfemoral Trinity system will have the same features as our transapical system,” says Wolfgang Goetz, founder and chief executive officer, a cardiac surgeon who has used many of the currently marketed TAVI systems. “The tremendous advantage of Trinity is that even when the valve is completely expanded and anchored above the annulus—unlike currently marketed TAVI systems—the Trinity valve may still be repositioned, retrieved, or kept in the same position. This feature is absolutely unique to Trinity and the reason why we have positioned Trinity as the Third-Generation TAVI system.”